Filing Details
- Accession Number:
- 0001209191-15-024140
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-09 17:00:38
- Reporting Period:
- 2015-03-05
- Filing Date:
- 2015-03-09
- Accepted Time:
- 2015-03-09 17:00:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1159036 | Halozyme Therapeutics Inc | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1291219 | J Kenneth Kelley | C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Blvd. San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-03-05 | 40,000 | $15.33 | 194,876 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.25 to $15.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
